News
Could 2025 be the year that endotoxin testing finally catches up with the 21st century? Unlike other areas of Pharmaceutical Quality Control where innovations such as data analytics and automation have driven extensive modernization, endotoxin testing has remained resolutely stuck in the past. This vital Quality Control procedure has until recently relied on outdated testing practices that require the blood of horseshoe crabs. Significantly, new authoritative standards have recently recognized alternative testing methods that can deliver the same important validation, without relying on animal-derived products.
What are these new standards and what could their integration mean for the future of endotoxin testing?
Swipe to discover more
-
bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
bioMérieux, a world leader in the field of in vitro diagnostics, announces an agreement to acquire the assets of Day Zero Diagnostics, a US-based infectious disease diagnostics company using genome sequencing and machine learning to combat the rise of antibiotic-resistant infections. -
Prevention & Management : What to do when an outbreak occurs ?
Have you ever been in a situation where you were not able to distinguish a simple cough from a real disease which could have dramatic outcomes for a horse and potentially contaminate the whole herd? When suspicion arises, the initial diagnostic relies on a precise examination by a veterinarian and an early pathogen identification through diagnosis. Good hygiene protocols for both the individual and the collective, and adapted treatment are needed as well. These two pillars play a critical role in safeguarding the health and well-being of our equine companions, as well as preventing potential economic losses and maintaining the overall stability of equine communities. -
bioMérieux Embarks its Customers in a Circular Economy Initiative
BIOLOOP™ is an innovative project to recycle plastic Petri dishes from infectious waste into new reagents packaging—reducing CO₂ emissions and supporting a circular economy in healthcare.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19